Navigation Links
Drug therapy shows significant benefit in treating a leading cause of childhood blindness
Date:2/16/2011

an get wonderful outcomes."

Mintz-Hittner, an attending physician at Children's Memorial Hermann Hospital and the Robert Cizik Eye Clinic, stressed that timing is critical with this drug therapy. If administered too early, in stages 1 and 2 of the disease, it can cause retinal dystrophy. Given too late, in stages 4-5 of the disease, the drug can accelerate retina detachment.

"In that window, as the abnormal vessels begin to proliferate but before the retinal begins to detach, that's when you want to treat," Mintz-Hittner said.

In addition to the significantly reduced recurrence rate for patients with retinopathy of prematurity in zone I, Mintz-Hittner said, compared with conventional laser therapy, the drug therapy appears to do the best job preserving vision. Plus, when administered, there is no need to intubate the baby and there is a faster recovery.

"Our first available treatment for babies with retinopathy of prematurity was cryotherapy," Mintz-Hittner said. "It was very painful and it wiped out all posterior ocular layers. The visual field was decreased and myopia or nearsightedness occurred. It was a long procedure 2 to 3 hours requiring intubation. With laser treatment, you still had to intubate, which could cause major setbacks for the baby, and field loss and myopia still occurred, but it was less painful and only destroyed the inner retinal layers."

"With this drug therapy, we use a few drops of anesthetic to numb the eye. We take a syringe with a tiny needle and administer a small amount of the drug directly into the eye. The whole process takes two to three minutes, and you begin to see results within 24 hours," she said. "The abnormal vessels virtually disappear and then normal vessels begin to grow out again. The field of vision is preserved and myopia is less."

The results of the study were so promising that Children's Memorial Hermann Hospital has discontinued the use of conventional laser ther
'/>"/>

Contact: Meredith Raine
Meredith.Raine@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. U of Alberta researcher discovers potential cancer therapy target
2. UTHealth, Athersys preclinical research on stem cell therapy for stroke presented at AHA conference
3. Photodynamic therapy against cancer
4. A loose grip provides better chemotherapy
5. Early tests find nanoshell therapy effective against brain cancer
6. New anti-HIV gene therapy makes T-cells resistant to HIV infection
7. Caffeine energizes cells, boosting virus production for gene therapy applications
8. Nanodisk gene therapy
9. Invention could improve cancer drug delivery, lessen harmful effects of chemotherapy
10. New breathing therapy reduces panic and anxiety by reversing hyperventilation
11. Missing molecules hold promise of therapy for pancreatic cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug therapy shows significant benefit in treating a leading cause of childhood blindness
(Date:6/17/2015)... , and HILDEN, Germany , June 17, ... ; Frankfurt Prime Standard: QIA) today launched new Investigator ® ... forensic laboratories in the United States . ... simultaneously analyze multiple key genomic markers (short tandem repeats or ... Quality Sensor to evaluate the quality of DNA in each ...
(Date:6/16/2015)... Fingerprint Cards has received an order of 375 ... from one of its module partners in Asia ... the third quarter 2015. The sensors will be used by ... Jörgen Lantto, CEO of FPC, comments: " This order   ... smartphone OEMs in integrating touch fingerprint sensors in   their ...
(Date:6/12/2015)... 12, 2015  Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring, announced the ... electronically capture, analyze and identify participants of a ... This system can: , ... and subsequent sign-on process is actually the person ...
Breaking Biology News(10 mins):QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5FPC Receives Order for Touch Fingerprint Sensors of 375 MSEK 2Securus Announces Patent Issued for Authorized Presence Verification During Video Visitation 2
... Although studies of alcohol,s effects on fetal growth have ... on long-term postnatal growth from human studies have been ... heavy prenatal alcohol exposure (PAE) on growth and body ... through to nine years of age, as well as ...
... to a NOAA-led paper published today in the journal ... mainly due to ships, have reduced the ability of ... each other by about two-thirds. From 2007 until ... Lab of Ornithology, NOAA Fisheries Northeast Fisheries Science Center, ...
... - Bureau of Reclamation Commissioner Michael L. Connor ... $1.2 million, and Reclamation will partner with other ... projects to benefit the Desert and Southern Rockies ... to provide more than $3.5 million for these ...
Cached Biology News:Tracking the effects of prenatal alcohol exposure through to 9 years of age 2Tracking the effects of prenatal alcohol exposure through to 9 years of age 3NOAA: Underwater noise decreases whale communications in Stellwagen Bank sanctuary 2WaterSMART funds $1.7 million for science projects in desert and southern Rockies LCCs 2WaterSMART funds $1.7 million for science projects in desert and southern Rockies LCCs 3
(Date:6/30/2015)... IL (PRWEB) , ... June 30, 2015 , ... ... effective August 14. She has accepted the position of vice president of instruction ... August 17. , “I greatly appreciated the opportunity to lead SIUE during ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... company, launched “Cannavoices,” an unprecedented digital video and broadcast initiative. Produced by filmmakers, ... most dynamic collection of legal medical cannabis stories ever assembled. , Cannavoices ...
(Date:6/29/2015)... , June 30, 2015   Pharnext SAS ... being developed for the treatment of Charcot-Marie-Tooth Type 1A (CMT1A), ... at the 2015 Peripheral Nerve Society (PNS) Biennial Meeting at ... , June 27 - July 2, 2015. ... on Wed July 1, 5p.m. to 7p.m. EDT: ...
(Date:6/29/2015)... ... , ... The global microfluidics market is expected to grow ... 2020). The market is mainly driven by the rising geriatric population, growing Asian ... of adequate healthcare and research infrastructure in emerging markets, dearth of skilled professionals ...
Breaking Biology Technology:SIUE’s Furst-Bowe Accepts VP of Instruction at CVTC 2SIUE’s Furst-Bowe Accepts VP of Instruction at CVTC 3Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 2Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 3Pharnext's PXT-3003 Featured in Multiple Presentations at 2015 Peripheral Nerve Society Biennial Meeting 2Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 2Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 3Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 4Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 5
... Principal Amount of Debt Exchanged for Convertible Preferred ... ... 8 Access Pharmaceuticals, Inc.,(OTC Bulletin Board: ACCP) announced today that ... entered,into agreements with institutional investors to purchase an aggregate of,$9.5 million ...
... Nov. 8 Holidays often induce stress,but caring for ... an,additional layer of pressure. Parents and caregivers can visit, ... specialists for expert advice on how to best manage ... receive a free,download of the ,Diabetes Fit Food, booklet ...
... MEDX ) today announced that Marc Rubin, M.D. has ... as a director on Medarex,s Board,effective November 1, 2007. ... Pharmaceutical, Inc., a,biopharmaceutical company publicly traded on the American ... was Head of Global Research and,Development for Bayer Schering ...
Cached Biology Technology:Access Pharmaceuticals Announces $19.5 Million Recapitalization 2Access Pharmaceuticals Announces $19.5 Million Recapitalization 3New Web Site Tools Help Alleviate Stress Associated with Caring for Children with Diabetes During the Holidays 2Medarex Announces Election of Marc Rubin as New Board Member 2
...
... • Mouse serum is collected off the clot fasted ... of age. Available Anticoagulants: N-02: ... K2EDTA N-08: Potassium Oxalate N-10: ... ACD N-07: CPD N-09: K3EDTA ...
The Varian 4000 GC/MS system offers three easily switchable ionization configurations: internal ionization (II), external ionization (EI) or hybrid chemical ionization (CI)...
GeneRacer is an advanced RACE (rapid amplification of cDNA ends) technique that improves the efficiency of amplifying full-length 5' and 3' cDNA ends. With the GeneRacer Kit you can:...
Biology Products: